|
[1]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.
|
|
[2]TORRE LA, BRAY F, SIEGEL RL, et al.Global cancer statistics, 2012[J].CA Cancer J Clin, 2015, 65 (2) :87-108.
|
|
[3]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2) :115-132.
|
|
[4]WANG FS, FAN JG, ZHANG Z, et al.The global burden of liver disease:the major impact of China[J].Hepatology, 2014, 60 (6) :2099-2108.
|
|
[5]LI X, CHEN Y, MA Z, et al.Effect of regulatory T cells and adherent cells on the expansion of HBc Ag-specific CD8+T cells in patients with chronic hepatitis B virus infection[J].Cell Immunol, 2010, 264 (1) :42-46.
|
|
[6]LI CD, CHEN XL, TIAN PF, et al.Correlation analysis of percentages of T lymphocyte subsets and CD4+CD25+regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J].J Clin Hepatol, 2015, 31 (4) :541-545. (in Chinese) 李彩东, 陈锡莲, 田鹏飞, 等.慢性乙型肝炎患者外周血中T淋巴细胞亚群和CD4+CD25+调节性T淋巴细胞的表达水平与HBV-DNA定量的相关分析[J].临床肝胆病杂志, 2015, 31 (4) :541-545.
|
|
[7]YANG PL, ALTHAGE A, CHUNG J, et al.Immune effectors required for hepatitis B virus clearance[J].Proc Natl Acad Sci USA, 2010, 107 (2) :798-802.
|
|
[8]RAZA S, CLIFFORD GS.Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma:a systematic review[J].British J Cancer, 2007, 96 (7) :1127-1134.
|
|
[9]WANG P, LI YC, YIN F.Relationship between preoperative HBV-DNA load and postoperative liver function recovery in patients with hepatitis B related hepatocellular carcinoma[J].J Hepatobiliary Surg, 2017, 25 (5) :370-373. (in Chinese) 王鹏, 李又春, 殷飞.乙肝相关性肝癌患者术前HBV-DNA载量水平与术后肝功能恢复的关系分析[J].肝胆外科杂志, 2017, 25 (5) :370-373.
|
|
[10]LIU H, WANG FM, LUO Y, et al.HBV promotes migration and invasion of hepatocellular carcinoma cell lines[J].Basic Clin Med, 2016, 36 (10) :1393-1399. (in Chinese) 刘辉, 王凤梅, 骆莹, 等.乙肝病毒促进肝癌细胞系的转移侵袭力[J].基础医学与临床, 2016, 36 (10) :1393-1399.
|
|
[11]SAITTA C, TRIPODI G, BARBERA A, et al.Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma[J].Liver Int, 2015, 35 (10) :2311-2317.
|
|
[12]GONG WF, LU SD, ZHONG JH, et al.Influence of preoperative antiviral therapy on HBV reactivation and liver function after liver resection in HBV-DNA-negative hepatocellular carcinoma patients[J].Chin J Clin Oncol, 2016, 43 (15) :668-673. (in Chinese) 龚文锋, 陆世东, 钟鉴宏, 等.术前抗病毒治疗对HBV-DNA阴性肝细胞癌患者术后病毒再激活及肝功能的影响[J].中国肿瘤临床, 2016, 43 (15) :668-673.
|
|
[13] FU WZ, YANG L, HU XQ, et al.Relationship between HBV DNAload and HBV-M, ALT, AST content in the serum of chronic hepatitis B patients[J].Int J Virol, 2015, 22 (2) :111-114. (in Chinese) 付万智, 杨丽, 胡晓勤.慢性乙肝患者血清HBV-DNA载量与HBV-M、ALT、AST含量的关系研究[J].国际病毒学杂志, 2015, 22 (2) :111-114.
|
|
[14]VIZZINI GB, LUCA A, MARINO IR.Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma[J].Ann Int Med, 2003, 138 (8) :691-692.
|
|
[15]LEE JI, KIM JK, CHANG HY, et al.Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus[J].J Gastroenterol Hepatol, 2014, 29 (5) :1019-1027.
|
|
[16]ZHONG S, YEO W, SCHRODER C, et al.High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy[J].J Viral Hepat, 2004, 11 (1) :55-59.
|
|
[17]HUANG G, LAU WY, SHEN F, et al.Preoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinoma[J].World J Surg, 2014, 38 (9) :2370-2376.
|
|
[18]YAO YT, AN ZM, LUO LY, et al.Relationship between preoperative hepatitis B virus DNA level and perioperative complications in patients with hepatitis B-related hepatocellular carcinoma[J].Chin J Gen Surg, 2016, 25 (1) :19-24. (in Chinese) 姚豫桐, 安志明, 罗兰云, 等.乙肝相关性肝癌术前乙型肝炎病毒DNA载量与围手术期并发症的关系[J].中国普通外科杂志, 2016, 25 (1) :19-24.
|
|
[19]XIE BX.Effect of antiviral therapy after radical surgery for hepatitis B-related liver cancer on patient prognosis[J].Chin J Cancer Prev Treat, 2016, 23 (s1) :164-165. (in Chinese) 谢碧霞.乙肝相关性肝癌根治性术后抗病毒治疗对于患者预后的影响[J].中华肿瘤防治杂志, 2016, 23 (s1) :164-165.
|
|
[20]AN HJ, JANG JW, SI HB, et al.Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2010, 25 (12) :1876-1882.
|
|
[21]YAN PG, WANG RY, ZHANG J, et al.Impact of preoperative hepatitis B virus levels on prognosis after primary and repeat hepatectomies for hepatocellular carcinoma patients-a retrospective study[J].J Gastrointest Surg, 2018, 22 (5) :1-12.
|
|
[22]WANG P, ZHU ZY, LI CL, et al.Over expression of Eph A2 in different hepatocellular carcinoma cell lines and its relationship with HBV infection[J].Basic Clin Med, 2013, 33 (12) :1590-1594. (in Chinese) 王鹏, 朱争艳, 李成龙, 等.Eph A2在不同肝癌细胞系中过表达及其与乙肝病毒感染相关[J].基础医学与临床, 2013, 33 (12) :1590-1594.
|
|
[23]LIANG WY, REN SD, DUN ZN, et al.Clinical observation of a144-week entecavir therapy for HBe Ag-positive chronic HBVcarriers with high viral load[J].Int J Virol, 2017, 24 (3) :187-191. (in Chinese) 梁文艳, 任树冬, 敦志娜, 等.恩替卡韦治疗高病毒载量HBe Ag阳性慢性HBV携带者144周的临床观察[J].国际病毒学杂志, 2017, 24 (3) :187-191.
|
|
[24]DING C, PAN F, HU HZ, et al.Efficacy of antiviral therapy in hepatocellular carcinoma patients with high HBV DNA levels after radical resection[J].J Clin Hepatol, 2014, 30 (7) :656-659. (in Chinese) 丁晨, 潘凡, 胡还章, 等.HBV-DNA高载量的肝细胞癌患者肝癌根治术后抗病毒治疗疗效观察[J].临床肝胆病杂志, 2014, 30 (7) :656-659.
|
|
[25]GUO XP, LIU YW, WANG W, et al.Treatment of liver cirrhosis with postoperative hepatocellular carcinoma with nucleoside analog[J].J Clin Hepatol, 2010, 26 (4) :425-427. (in Chinese) 郭西萍, 刘彦威, 王婉, 等.核苷类抗病毒治疗伴活动性肝硬化肝癌术后的临床观察[J].临床肝胆病杂志, 2010, 26 (4) :425-427.
|
|
[26]CHEN CJ, YANG HI, ILOEJE UH, et al.Hepatitis B virus DNAlevels and outcomes in chronic hepatitis B[J].Hepatology, 2009, 49 (5 Suppl) :72-84.
|
|
[27]HUANG G, LI PP, LAU WY, et al.Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels:a randomized controlled trial[J].Ann Surg, 2018.[Epub ahead of print]
|
|
[28]SAMUEL D, FERAY C, BISMUTH H.Hepatitis viruses and liver transplantation[J].J Gastroenterol Hepatol, 1997, 12 (9-10) :s335.
|
|
[29]MCCAUGHAN GW.Prevention of post liver transplant HBV recurrence[J].Hepatol Int, 2011, 5 (4) :876-881.
|
|
[30]WANG FS, SHEN ZY, YUAN GY, et al.The influence factors for hepatitis B virus re-infection after liver transplantation[J].Chin JPrac Intern Med, 2009, 29 (12) :1112-1114. (in Chinese) 王凤水, 沈中阳, 袁桂玉, 等.肝移植术后乙型肝炎病毒再感染的影响因素研究[J].中国实用内科杂志, 2009, 29 (12) :1112-1114.
|
|
[31]ZHENG JF, HAN DK, LI L, et al.Intramuscular hepatitis B immunoglobulin combined with entecavir for long-term prophylaxis of hepatitis B re-infection after liver transplantation[J].World Chin J Dig, 2009, 17 (7) :716-719. (in Chinese) 郑俊福, 韩大康, 李丽, 等.恩替卡韦联合乙肝免疫球蛋白预防肝移植术后乙肝再感染[J].世界华人消化杂志, 2009, 17 (7) :716-719.
|
|
[32]LEE S, KWON CH, MOON HH, et al.Antiviral treatment for hepatitis B virus recurrence following liver transplantation[J].Clin Transplant, 2013, 27 (5) :e597-e604.
|
DownLoad: